• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT TRIMA ACCEL; TRIMA LRS PLT W/FILTER+SAMPLER+AUTO

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT TRIMA ACCEL; TRIMA LRS PLT W/FILTER+SAMPLER+AUTO Back to Search Results
Catalog Number 82383
Device Problems Excess Flow or Over-Infusion (1311); Adverse Event Without Identified Device or Use Problem (2993); Output Problem (3005)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 05/02/2022
Event Type  malfunction  
Event Description
The customer would like the run data file investigated to determine a possible cause for the overflow of red blood cells (rbc) into the platelet concentrate when the additive solution was added.There was not a transfusion recipient or patient involved at the time of the pas addition, therefore no patient information is reasonably known at the time of the event.The platelet collection set is not available for return because it was discarded by the customer.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
 
Manufacturer Narrative
Investigtion: one used trima set was received for investigation.Initial observations noted the ac and saline bags, and the product bags were rf sealed and removed prior to return.Visual inspection noted blood up to and in the channel, reservoir and vent bag.Red fluid is observed in the plasma line through the cassette, and in the platelet line through cassette and platelet tubing from centrifuge, above the mini pinch clamp.The mini pinch clamps are noted on the correct lines and in the closed position.The set was inspected for any kinks, misassemblies or missing parts and none were found.Investigation is in process.A follow up report will be provided.
 
Event Description
The customer would like the run data file investigated to determine a possible cause for the overflow of red blood cells (rbc) into the platelet concentrate when the additive solution was added.There was not a transfusion recipient or patient involved at the time of the pas addition, therefore no patient information is reasonably known at the time of the event.The platelet collection set is not available for return because it was discarded by the customer.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Investigtion: one used trima set was received for investigation.Initial observations noted the ac and saline bags, and the product bags were rf sealed and removed prior to return.Visual inspection noted blood up to and in the channel, reservoir and vent bag.Red fluid is observed in the plasma line through the cassette, and in the platelet line through cassette and platelet tubing from centrifuge, above the mini pinch clamp.The mini pinch clamps are noted on the correct lines and in the closed position.The set was inspected for any kinks, misassemblies or missing parts and none were found.The run data file (rdf) was analyzed for this event.The analysis of the run data file during the pas addition phase showed rbcs consistently passed the rbc detector from the beginning of the process.This can happen if one or more of the 3 channel clamps are left pen or if partial occluded during the pas addition phase.If these claps are not fully occluding the channel line, fluid from the channel containing rbcs and wbcs, is pulled up and can enter the product bags causing the product to turn pink or red.It is probably that the contamination of the product happened during the post-collection process.There are two verifications in place that check the status of the channel clamps.One is active during prime of the pas solution and uses the return reservoir volume to confirm if the clamps are closed.The verification during the addition phase is based on a change of the rbc detector reading.If the reading increases too much beyond the baseline, then an alert is generated.At all times during the pas addition, the tests were in place but as the volume discrepancy was not triggered, the system used the existing baseline which upon pas addition did not recognize the additional rbcs in the line.This indicates that one or more of the 3 channel lines were partially clamped and not fully occluded from the beginning of pas addition.The device history records (dhr) were reviewed for this lot.There were no events noted in the dhr that would have contributed to the elevated wbc count experienced by the customer.Root cause: the analysis of the run data file during the pas addition phase showed rbcs consistently passed the rbc detector from the beginning of the process.This can happen if one or more of the 3 channel clamps are left pen or if partial occluded during the pas addition phase.If these claps are not fully occluding the channel line, fluid from the channel containing rbcs and wbcs, is pulled up and can enter the product bags causing the product to turn pink or red.It is probably that the contamination of the product happened during the post-collection process.There are two verifications in place that check the status of the channel clamps.One is active during prime of the pas solution and uses the return reservoir volume to confirm if the clamps are closed.The verification during the addition phase is based on a change of the rbc detector reading.If the reading increases too much beyond the baseline, then an alert is generated.At all times during the pas addition, the tests were in place but as the volume discrepancy was not triggered, the system used the existing baseline which upon pas addition did not recognize the additional rbcs in the line.This indicates that one or more of the 3 channel lines were partially clamped and not fully occluded from the beginning of pas addition.
 
Event Description
The customer would like the run data file investigated to determine a possible cause for the overflow of red blood cells (rbc) into the platelet concentrate when the additive solution was added.There was not a transfusion recipient or patient involved at the time of the pas addition, therefore no patient information is reasonably known at the time of the event.The platelet collection set is not available for return because it was discarded by the customer.This product is not available within the us, but this report is being filed due to an alleged failure that could occur on a similarly marketed device platform cleared for use by the fda.
 
Manufacturer Narrative
This report is being filed to provide additional information in b.6 and h.10.Investigtion: one used trima set was received for investigation.Initial observations noted the ac and saline bags, and the product bags were rf sealed and removed prior to return.Visual inspection noted blood up to and in the channel, reservoir and vent bag.Red fluid is observed in the plasma line through the cassette, and in the platelet line through cassette and platelet tubing from centrifuge, above the mini pinch clamp.The mini pinch clamps are noted on the correct lines and in the closed position.The set was inspected for any kinks, misassemblies or missing parts and none were found.The run data file (rdf) was analyzed for this event.The analysis of the run data file during the pas addition phase showed rbcs consistently passed the rbc detector from the beginning of the process.This can happen if one or more of the 3 channel clamps are left pen or if partial occluded during the pas addition phase.If these claps are not fully occluding the channel line, fluid from the channel containing rbcs and wbcs, is pulled up and can enter the product bags causing the product to turn pink or red.It is probably that the contamination of the product happened during the post-collection process.There are two verifications in place that check the status of the channel clamps.One is active during prime of the pas solution and uses the return reservoir volume to confirm if the clamps are closed.The verification during the addition phase is based on a change of the rbc detector reading.If the reading increases too much beyond the baseline, then an alert is generated.At all times during the pas addition, the tests were in place but as the volume discrepancy was not triggered, the system used the existing baseline which upon pas addition did not recognize the additional rbcs in the line.This indicates that one or more of the 3 channel lines were partially clamped and not fully occluded from the beginning of pas addition.Investigation is in process.A follow up report will be provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TRIMA ACCEL
Type of Device
TRIMA LRS PLT W/FILTER+SAMPLER+AUTO
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
Manufacturer (Section G)
TERUMO BCT
10810 w. collins ave
lakewood CO 80215
Manufacturer Contact
scot hilden
10810 w. collins ave
lakewood, CO 80215
MDR Report Key14645323
MDR Text Key301358354
Report Number1722028-2022-00192
Device Sequence Number1
Product Code GKT
Combination Product (y/n)N
Reporter Country CodeFR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 06/09/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/01/2023
Device Catalogue Number82383
Device Lot Number2105252130
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/31/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/16/2022
Initial Date FDA Received06/09/2022
Supplement Dates Manufacturer Received06/15/2022
06/15/2022
Supplement Dates FDA Received07/01/2022
07/20/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured05/27/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-